Next Article in Journal
Clinical Results of Hypomethylating Agents in AML Treatment
Previous Article in Journal
Inflammation and Cell Death in Age-Related Macular Degeneration: An Immunopathological and Ultrastructural Model
Previous Article in Special Issue
Obesity as an Early Symptom of the AMIS Syndrome
Open AccessReview

The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus

1
School of Health Nursing & Midwifery, the University of the West of Scotland, Paisley PA1 2BE, UK
2
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm SE171 76, Sweden
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2014, 3(4), 1561-1574; https://doi.org/10.3390/jcm3041561
Received: 23 September 2014 / Revised: 21 November 2014 / Accepted: 5 December 2014 / Published: 22 December 2014
(This article belongs to the Special Issue Obesity, Diabetes and Metabolic Syndrome)
The insulin-like growth factor (IGF) system, acting in concert with other hormone axes, is important in normal metabolism. In obesity, the hyperinsulinaemia that accompanies peripheral insulin resistance leads to reduced growth hormone (GH) secretion, while total IGF-I levels are relatively unchanged due to increased hepatic GH sensitivity. IGF-binding protein (IGFBP)-1 levels are suppressed in relation to the increase in insulin levels in obesity and low levels predict the development of type 2 diabetes several years later. Visceral adiposity and hepatic steatosis, along with a chronic inflammation, contribute to the IGF system phenotype in individuals with metabolic syndrome and type 2 diabetes mellitus, including changes in the normal inverse relationship between IGFBP-1 and insulin, with IGFBP-1 concentrations that are inappropriately normal or elevated. The IGF system is implicated in the vascular and other complications of these disorders and is therefore a potential therapeutic target. View Full-Text
Keywords: insulin-like growth factor; IGFBP; GH; obesity; type 2 diabetes insulin-like growth factor; IGFBP; GH; obesity; type 2 diabetes
Show Figures

Figure 1

MDPI and ACS Style

Lewitt, M.S.; Dent, M.S.; Hall, K. The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus. J. Clin. Med. 2014, 3, 1561-1574.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop